2115479 Alberta Ltd. – Trademark Portfolio
Entity Type: 03
2115479 Alberta Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CANARY IN THE HOME and RESIDE HEALTHY STANDARD. The owner is based in Calgary, Alberta.
5539 1st Street SE
Calgary, Alberta T2H1H9 , CA
Showing of trademarks Trademarks
Trademark Classifications
2115479 Alberta Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Building materials (non-metallic); non-metallic rigid pipes for building
Frequently Asked Questions
How many trademarks does 2115479 Alberta Ltd. have?
2115479 Alberta Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does 2115479 Alberta Ltd. file in?
2115479 Alberta Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business), Class 19 (Building Materials). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are 2115479 Alberta Ltd.'s most well-known trademarks?
2115479 Alberta Ltd.'s registered trademark portfolio includes well-known marks such as CANARY IN THE HOME and RESIDE HEALTHY STANDARD. These are among 2 currently registered trademarks in the portfolio.
What is 2115479 Alberta Ltd.'s trademark registration success rate?
2115479 Alberta Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.